Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Developmental studies in fragile X syndrome.
Razak KA, Dominick KC, Erickson CA. Razak KA, et al. Among authors: erickson ca. J Neurodev Disord. 2020 May 2;12(1):13. doi: 10.1186/s11689-020-09310-9. J Neurodev Disord. 2020. PMID: 32359368 Free PMC article. Review.
Emerging pharmacologic treatment options for fragile X syndrome.
Schaefer TL, Davenport MH, Erickson CA. Schaefer TL, et al. Among authors: erickson ca. Appl Clin Genet. 2015 Apr 7;8:75-93. doi: 10.2147/TACG.S35673. eCollection 2015. Appl Clin Genet. 2015. PMID: 25897255 Free PMC article. Review.
Pharmacotherapy for Fragile X Syndrome: Progress to Date.
Davenport MH, Schaefer TL, Friedmann KJ, Fitzpatrick SE, Erickson CA. Davenport MH, et al. Among authors: erickson ca. Drugs. 2016 Mar;76(4):431-45. doi: 10.1007/s40265-016-0542-y. Drugs. 2016. PMID: 26858239 Review.
Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety.
Schaefer TL, Davenport MH, Grainger LM, Robinson CK, Earnheart AT, Stegman MS, Lang AL, Ashworth AA, Molinaro G, Huber KM, Erickson CA. Schaefer TL, et al. Among authors: erickson ca. J Neurodev Disord. 2017 Jun 12;9:6. doi: 10.1186/s11689-017-9184-y. eCollection 2017. J Neurodev Disord. 2017. PMID: 28616095 Free PMC article.
Fragile X targeted pharmacotherapy: lessons learned and future directions.
Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, Fitzpatrick SE, Brown WT, Budimirovic D, Hagerman RJ, Hessl D, Kaufmann WE, Berry-Kravis E. Erickson CA, et al. J Neurodev Disord. 2017 Jun 12;9:7. doi: 10.1186/s11689-017-9186-9. eCollection 2017. J Neurodev Disord. 2017. PMID: 28616096 Free PMC article. Review.
257 results